Abstract
Purpose
To investigate the association between high-risk histopathological features (HRHFs) and clinical indicators in advanced retinoblastoma and to identify independent predictors of high-risk disease.
Methods
This single-center retrospective cohort study analyzed 236 enucleated eyes from patients with retinoblastoma treated at a tertiary referral center in Tehran, between 2001 and 2024. Clinical data and histopathological features were extracted. Eyes were classified into low-risk and high-risk groups based on HRHFs. Statistical analyses included univariate and multivariate logistic regression to identify factors independently associated with HRHFs.
Results
Of the 236 eyes, 58 (24.6%) demonstrated HRHFs. Patients with high-risk tumors were significantly older at diagnosis (31.9 ± 19.2 vs. 22.3 ± 18.9 months, p = 0.017) and enucleation (37.3 ± 24.8 vs. 26.6 ± 23.3 months, p = 0.009). In multivariate analysis, four variables remained independently associated with HRHFs: increasing age at enucleation (OR = 1.015; 95% CI: 1.001–1.029; p = 0.038), higher tumor height (OR = 1.171; 95% CI: 1.073–1.279; p < 0.001), iris neovascularization (OR = 60.12; 95% CI: 6.93–521; p < 0.001), and both exophytic endophytic growth pattern (OR = 11.92; 95% CI: 2.04–70.28; p = 0.006). Rosette subtype, growth pattern, and tumor necrosis were not independently predictive after adjustment.
Conclusions
Older age at enucleation, iris neovascularization, tumor height, and a combined exophytic endophytic tumor growth patterns are strong independent predictors of high-risk histopathologic features in retinoblastoma. Recognizing these indicators preoperatively may assist in risk stratification and guide treatment choices to enhance outcomes.
Get full access to this article
View all access options for this article.